CAPTRUST Financial Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-821
| Closed | -$3K | – | 3914 |
|
|
2022
Q2 | $3K | Sell |
821
-200
| -20% | -$731 | ﹤0.01% | 4346 |
|
|
2022
Q1 | $7K | Hold |
1,021
| – | – | ﹤0.01% | 3999 |
|
|
2021
Q4 | $12K | Hold |
1,021
| – | – | ﹤0.01% | 3624 |
|
|
2021
Q3 | $19K | Hold |
1,021
| – | – | ﹤0.01% | 3206 |
|
|
2021
Q2 | $22K | Buy |
1,021
+60
| +6% | +$1.29K | ﹤0.01% | 3048 |
|
|
2021
Q1 | $20K | Buy |
961
+241
| +33% | +$5.02K | ﹤0.01% | 3007 |
|
|
2020
Q4 | $19K | Buy |
720
+350
| +95% | +$9.24K | ﹤0.01% | 2283 |
|
|
2020
Q3 | $8K | Buy |
+370
| New | +$8K | ﹤0.01% | 2383 |
|